Role of ET-1 in the regulation of coronary circulation

被引:16
作者
Lavallée, M
Thorin, E
机构
[1] Univ Montreal, Dept Physiol, Fac Med, Montreal, PQ H1T 1C8, Canada
[2] Univ Montreal, Dept Surg, Fac Med, Montreal, PQ H1T 1C8, Canada
关键词
endothelin; ET receptors; coronary vessels; coronary blood flow; nitric oxide; shear stress; atherosclerosis; humans; animals;
D O I
10.1139/Y03-014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Given that circulating ET levels in heart failure, in particular, may reach physiological threshold for coronary constrictor responses, the primary objective of the present review is to consider coronary vessels as an important target for circulating and locally produced endothelin(s). In healthy vessels, ET-1 causes biphasic coronary responses characterized by a transient dilation of large and small arteries followed by a sustained constriction. ETB receptors are pivotal in the early dilation of resistance vessels, whereas dilation of conductance vessels may be a secondary phenomenon triggered by flow increases. Exogenous ET-1 causes coronary constriction almost exclusively through ETA receptor activation. Human and canine large epicardial coronary vessels display significant baseline ET-1 dependent tone in vitro and in vivo, an ETA-dependent process. In contrast, ETB receptors located on smooth muscle cells are apparently less important for producing constrictor responses. NO production may serve as an important counter-regulatory mechanism to limit ET-dependent effects on coronary vessels. Conversely, in a dysfunctional endothelium, the loss of NO may augment ET-1 production and activity. By lifting the ET-dependent burden from coronary vessels, ET receptor blockade should help to ensure a closer match between cardiac metabolic demand and coronary perfusion.
引用
收藏
页码:570 / 577
页数:8
相关论文
共 59 条
[51]   Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium [J].
Traverse, JH ;
Judd, D ;
Bache, RJ .
CIRCULATION, 1996, 93 (03) :558-566
[52]  
WAGNER OF, 1992, J BIOL CHEM, V267, P16066
[53]   DILATION AND CONSTRICTION OF LARGE CORONARY-ARTERIES IN CONSCIOUS DOGS BY ENDOTHELIN [J].
WANG, J ;
ZEBALLOS, GA ;
KALEY, G ;
HINTZE, TH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05) :H1379-H1386
[54]   CHARACTERIZATION OF ENDOTHELIN-1-INDUCED VASCULAR EFFECTS IN THE RAT-HEART BY USING ENDOTHELIN RECEPTOR ANTAGONISTS [J].
WANG, QD ;
LI, XS ;
PERNOW, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 271 (01) :25-30
[55]   Contribution of endothelin to the coronary vasoconstriction in the isolated rat heart induced by nitric oxide synthase inhibition [J].
Wang, QD ;
Gonon, A ;
Shimizu, M ;
Sjöquist, PO ;
Pernow, J .
ACTA PHYSIOLOGICA SCANDINAVICA, 1998, 163 (04) :325-330
[56]  
WATANABE S, 1995, AM J PHYSIOL-HEART C, V268, pH1276, DOI 10.1152/ajpheart.1995.268.3.H1276
[57]   A NOVEL POTENT VASOCONSTRICTOR PEPTIDE PRODUCED BY VASCULAR ENDOTHELIAL-CELLS [J].
YANAGISAWA, M ;
KURIHARA, H ;
KIMURA, S ;
TOMOBE, Y ;
KOBAYASHI, M ;
MITSUI, Y ;
YAZAKI, Y ;
GOTO, K ;
MASAKI, T .
NATURE, 1988, 332 (6163) :411-415
[58]   TISSUE ENDOTHELIN-1 IMMUNOREACTIVITY IN THE ACTIVE CORONARY ATHEROSCLEROTIC PLAQUE - A CLUE TO THE MECHANISM OF INCREASED VASOREACTIVITY OF THE CULPRIT LESION IN UNSTABLE ANGINA [J].
ZEIHER, AM ;
GOEBEL, H ;
SCHACHINGER, V ;
IHLING, C .
CIRCULATION, 1995, 91 (04) :941-947
[59]   Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist [J].
Zhang, Y ;
Oliver, JR ;
Horowitz, JD .
CARDIOVASCULAR RESEARCH, 1998, 39 (03) :665-673